Blog Archives - Page 2 of 4

Export Investors and Companies by Location

CipherBio PRO Users Explore Hot Markets and Deal Activity by City, State and Country

CipherBio Data TeamJuly 12, 2021

You dove into the CipherBio ecosystem, discovering companies and investors rooted in life science. You also asked for something new: location specific lists for export. We are happy to announce we’ve delivered on that request and those location pages are now live and ready for you to explore, just as you have been with company […] READ MORE

Record Breaking Numbers in Life Science IPOs

CipherBio Data TeamJuly 6, 2021

The number of biotechs entering the public markets is at an all-time high, with 2020 breaking all biotech IPO records, and 2021 on track to rival these numbers. The latest CipherBio PRO data insight showcases these groundbreaking numbers. From 2019 to Q2 2021 over 220 companies went public with deals totaling $40+ Billion in IPO […] READ MORE

SVB Clients Receive Preferred Discounts on CipherBio PRO With Access to $580B+ in Global Life Science VC Funding

CipherBio Data TeamJune 28, 2021

SVB Financial Group built and funded CipherBio to help Founders and CEOs raise capital. CipherBio PRO provides companies & VCs with access to $580B+ in global life science VC funding activity. Most funding databases cost $5K to $15K per seat for an annual subscription. CipherBio is aware that Pre A companies cannot afford $5K+ per […] READ MORE

Life Science M&A Focused on Immunotherapy and Antibodies

CipherBio Data TeamJune 21, 2021

The life science M&A trend is not slowing down. Nearly $30B has been poured into life science acquisitions year to date through May 2021. Not only does the CipherBio PRO M&A Insights reveal the top deals in 2019-2021, acquirers and investors, but it also highlights the data and scientific work behind these billion-dollar deals. READ MORE

Download $520B+ of Funding Data to Excel to Build Investor and Company Lists From CipherBio PRO

Matt GibbsMay 26, 2021

We listened to our CipherBio PRO VC and CEO users and increased access to download $520B of life science funding deals to Excel. As a former VC for 20 years and founder of CipherBio@svb, I get excited that CipherBio PRO investor and company lists help CEOs raise capital and support investors in sourcing deals. READ MORE

metabolic

CipherBio PRO Dives Into the Booming Metabolic Disorder Sector

CipherBio Data TeamMay 17, 2021

Here’s an energizing topic: metabolism. Metabolism is the essential and fundamental process your body performs to make energy from the food you eat. But when just one step along the complex metabolic process fails, the body retains either too much or too little of one of the many essential substances it needs to maintain optimal […] READ MORE

CRISPRgene therapy

NPR Has Its Eye on Landmark Gene-Editing Experiment to Restore Vision

CipherBio Data TeamMay 12, 2021

We’ve been watching advances in gene therapy that bring hope to those who suffer vision loss or blindness due to genetic conditions. And we’re not the only ones. This just in: NPR recently interviewed patients involved in a landmark study using a gene-editing technique called CRISPR. NPR is the first to interview these patients. READ MORE

PRO Tip: Submit the Deals You Conducted or Know About

CipherBio Data TeamMay 10, 2021

Together, with our users, we make this life science ecosystem stronger. Want to know one way you can help? Here’s a PRO Tip: Submit a Deal. If you know about a deal or were part of one that you don’t see in our heaps of data, we absolutely want to hear about it. READ MORE

CRISPReye diseasesgene therapy

Gene Therapy Building Long-Awaited Momentum

CipherBio Data TeamMay 5, 2021

Gene therapy is one of the hottest, most eye-opening areas in the life sciences right now. Its earliest victories happened more than 30 years ago, but, since then, gene therapy has struggled to build momentum — until now. Ashanthi DeSilva owes her life to that early success. READ MORE

COVID-19

Life Science Companies Pivot To Fight COVID-19

CipherBio Data TeamMay 3, 2021

Doctors, scientists, health officials, world leaders and regular citizens around the globe breathed a collective sigh of relief late last year as vaccines to combat COVID-19 became a reality. The end of 2020 and beginning of 2021 presented three approved vaccines in the U.S., and distribution of those vaccines began shortly after their validation. READ MORE

New Feature Allows PRO Users To Download Investor Insights

CipherBio Data TeamApril 28, 2021

In this life science funding ecosystem, our subscribers have shown us we are truly stronger together. You asked for the ability to download data. It has been the single most popular request among CipherBio users. You asked. We delivered. READ MORE

PRO Tip: Conduct Lightning Fast Research In Just a Few Clicks

CipherBio Data TeamApril 21, 2021

When we say your most important investment insights are just a click away, we mean it. We built for CipherBio PRO with rapid investment research in mind. Every bar chart, every clinical phase, every map is interactive and clickable. And every click refines your search and sharpens your business intelligence. READ MORE

Subscribe

Premium Investor Insights